Chemoinformaics analysis of CHAMAZULENE-CARBOXYLIC-ACID
| Molecular Weight | 228.291 | nRot | 2 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 12 |
| Exact Molecular Weight | 228.115 | nRing | 2 |
| Solubility: LogS | -4.155 | nHRing | 0 |
| Solubility: LogP | 4.017 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
| nHA | 1 | APOL | 37.3227 |
| nHD | 1 | BPOL | 16.9193 |
| QED | 0.852 |
| Synth | 2.362 |
| Natural Product Likeliness | 0.156 |
| NR-PPAR-gamma | 0.961 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.023 |
| HIA | 0.004 |
| CACO-2 | -4.587 |
| MDCK | 0.0000263 |
| BBB | 0.345 |
| PPB | 0.970438 |
| VDSS | 0.264 |
| FU | 0.0142858 |
| CYP1A2-inh | 0.391 |
| CYP1A2-sub | 0.899 |
| CYP2c19-inh | 0.177 |
| CYP2c19-sub | 0.405 |
| CYP2c9-inh | 0.194 |
| CYP2c9-sub | 0.945 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.416 |
| CYP3a4-inh | 0.089 |
| CYP3a4-sub | 0.239 |
| CL | 0.669 |
| T12 | 0.35 |
| hERG | 0.025 |
| Ames | 0.026 |
| ROA | 0.404 |
| SkinSen | 0.065 |
| Carcinogencity | 0.095 |
| EI | 0.257 |
| Respiratory | 0.033 |
| NR-Aromatase | 0.025 |
| Antiviral | No |
| Prediction | 0.696455 |